Nucleic Acid Tests for Diagnosing Smear-Negative TB in Uganda
Author Information
Author(s): Keertan Dheda, Davis J. Lucian, Huang Laurence, Worodria William, Masur Henry, Cattamanchi Adithya, Huber Charles, Miller Cecily, Conville Patricia S., Murray Patrick, Kovacs Joseph A.
Primary Institution: University of Cape Town, South Africa
Hypothesis
Can nucleic acid amplification tests improve the diagnosis of smear-negative tuberculosis in a high HIV-prevalence setting?
Conclusion
Nucleic acid amplification tests showed moderate sensitivity and high specificity for tuberculosis in a predominantly HIV-seropositive population with negative sputum smears.
Supporting Evidence
- Of 211 patients enrolled, 170 (81%) were HIV-seropositive.
- Seventy-five patients (36%) had culture-confirmed TB.
- The MTD test correctly identified 18 (24%) TB patients not treated at discharge.
Takeaway
This study looked at new tests to find tuberculosis in people who don't show it in their cough samples. The tests can help doctors find more cases of TB, especially in people with HIV.
Methodology
The study enrolled 211 adults with cough and negative sputum smears, testing sputum for Mycobacterium tuberculosis DNA using two nucleic acid amplification tests.
Potential Biases
Potential biases include the quality of microscopy and culture used to define the eligible population.
Limitations
The tests were performed in a research lab away from the clinical site, which may have affected sensitivity; also, the study did not include liquid mycobacterial culture in the reference standards.
Participant Demographics
Median age was 35 years, with 81% being HIV-seropositive and a median CD4+ T-cell count of 78 cells/µL.
Statistical Information
P-Value
0.019
Confidence Interval
95% CI 28–51
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website